SitesBLAST
Comparing WP_012759819.1 NCBI__GCF_000023185.1:WP_012759819.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
1gpmA Escherichia coli gmp synthetase complexed with amp and pyrophosphate (see paper)
52% identity, 100% coverage: 3:520/520 of query aligns to 1:501/501 of 1gpmA
- active site: G57 (≠ S59), C84 (= C86), Y85 (= Y87), H179 (= H176), E181 (= E178), D237 (= D234), K357 (= K376)
- binding adenosine monophosphate: G231 (≠ A228), L232 (= L229), S233 (= S230), V258 (= V255), F313 (= F310)
- binding pyrophosphate 2-: S233 (= S230), G235 (= G232), V236 (= V233), D237 (= D234), S238 (= S235), K357 (= K376)
5tw7F Crystal structure of a gmp synthase (glutamine-hydrolyzing) from neisseria gonorrhoeae
50% identity, 100% coverage: 1:520/520 of query aligns to 1:490/490 of 5tw7F
Q8IJR9 GMP synthase [glutamine-hydrolyzing]; PfGMPS; Glutamine amidotransferase; Guanosine monophosphate synthetase; EC 6.3.5.2 from Plasmodium falciparum (isolate 3D7) (see 3 papers)
41% identity, 99% coverage: 8:520/520 of query aligns to 7:555/555 of Q8IJR9
- Y18 (≠ V19) mutation to F: Slight increase in affinity for glutamine. No defect in glutaminase activity.
- H20 (≠ Q21) mutation to A: Slight decrease in affinity for glutamine. 1.8-fold increase in affinity for ATP. Slight increase in affinity for XMP. Moderate reduction in glutaminase activity.
- K24 (≠ R25) mutation to L: 50 percent decrease in glutaminase activity. 5.3-fold decrease in affinity for glutamine. 1.7-fold increase in affinity for ATP. 2.8-fold decrease in affinity for XMP.
- R25 (= R26) mutation to L: No effect on glutaminase activity. 1.4-fold decrease in affinity for glutamine.
- C89 (= C86) mutation to A: Loss of glutaminase activity, however, glutamine binding is not affected. In presence of exogenous ammonia, the amination of XMP to produce GMP is normal. 2.3-fold decrease in affinity for ATP and 1.8-fold decrease in affinity for XMP. 2.9-fold decrease in affinity for ATP and 1.9-fold decrease in affinity for XMP; when associated with A-113.
- Q93 (= Q90) binding L-glutamine
- C113 (≠ R110) mutation to A: 2.9-fold decrease in affinity for ATP and 1.9-fold decrease in affinity for XMP; when associated with A-89.
- K160 (≠ W126) mutation to L: No effect on glutaminase activity. 1.2-fold decrease in affinity for ATP. 1.8-fold decrease in affinity for XMP.
- W167 (= W135) mutation to F: Slight decrease in affinity for glutamine. Slight increase in glutaminase activity.
- N169 (≠ S137) binding L-glutamine; mutation to S: Slight increase in affinity for glutamine. No defect in glutaminase activity.
- D172 (= D140) binding L-glutamine; mutation to A: 172-fold decrease in affinity for glutamine. Severe loss of glutaminase activity.
- H208 (= H176) binding L-glutamine
- Y212 (≠ V180) mutation to W: 2.7-fold decrease in affinity for glutamine. No defect in glutaminase activity.
- E213 (≠ H181) mutation to A: 40 percent decrease in glutaminase activity. 1.4-fold decrease in affinity for glutamine. 1.3-fold decrease in affinity for ATP. 1.8-fold decrease in affinity for XMP.
- R336 (= R303) binding XMP
- D371 (= D335) Important for ATPPase activity; mutation to A: Impaired formation of adenyl-XMP intermediate. Slight increase in glutaminase activity.
- E374 (= E338) mutation to L: 8.9-fold decrease in affinity for ammonia. Severe loss of glutaminase activity.
- K376 (≠ S341) mutation to L: 20 percent decrease in glutaminase activity. 4.4-fold decrease in affinity for glutamine. 1.8-fold decrease in affinity for XMP.
- K386 (= K351) mutation to L: Severe loss of ATP pyrophosphatase (ATPPase) activity. 80 percent decrease in glutaminase activity. Impaired GMP formation.
- T387 (≠ S352) mutation to A: No effect on ATP pyrophosphatase (ATPPase) activity. 20 percent decrease in glutaminase activity. No effect on GMP formation.
- H388 (= H353) Important for ATPPase activity; mutation to A: Moderate decrease in ATP pyrophosphatase (ATPPase) activity. Reduces 49 percent decrease in glutaminase activity. Impaired GMP formation.
- H389 (= H354) Important for ATPPase activity; mutation to A: Loss of ATP pyrophosphatase (ATPPase) activity. 67 percent decrease in glutaminase activity. Impaired GMP formation.
- N390 (= N355) mutation to A: No effect on ATP pyrophosphatase (ATPPase) activity. Increases glutaminase activity. Loss of GMP formation.
- K411 (= K376) mutation to L: 70 percent decrease in glutaminase activity. Loss of GMP formation.
- D412 (= D377) mutation to A: 30 percent decrease in glutaminase activity. 7.9-fold decrease in affinity for glutamine.
- D413 (≠ E378) mutation to A: 35 percent decrease in glutaminase activity. 3.6-fold decrease in affinity for glutamine.
- K415 (≠ R380) mutation to L: Increases glutaminase activity. 4.2-fold decrease in affinity for ATP.
- Q476 (= Q441) binding XMP
- R539 (= R504) mutation to L: 85 percent decrease in glutaminase activity.
- K547 (= K512) binding XMP; mutation to L: 85 percent decrease in glutaminase activity.
- I552 (= I517) binding XMP
- E553 (= E518) binding XMP; mutation to L: 85 percent decrease in glutaminase activity.
- E555 (= E520) mutation to L: 20 percent decrease in glutaminase activity. No effect on GMP formation.
2ywcA Crystal structure of gmp synthetase from thermus thermophilus in complex with xmp
48% identity, 98% coverage: 10:520/520 of query aligns to 2:475/475 of 2ywcA
- active site: G51 (≠ S59), R53 (≠ A61), C78 (= C86), Y79 (= Y87), H164 (= H176), E166 (= E178), D221 (= D234), K343 (= K376)
- binding xanthosine-5'-monophosphate: R288 (= R303), P366 (= P399), G367 (= G400), P368 (= P401), Q408 (= Q441), K467 (= K512), T471 (= T516), I472 (= I517), E473 (= E518)
4wioA Crystal structure of the c89a gmp synthetase inactive mutant from plasmodium falciparum in complex with glutamine (see paper)
39% identity, 99% coverage: 8:520/520 of query aligns to 1:525/525 of 4wioA
- active site: G52 (≠ S59), A83 (≠ C86), Y84 (= Y87), H197 (= H176), E199 (= E178), D255 (= D234), K393 (= K376)
- binding glutamine: Q87 (= Q90), N158 (≠ S137), H159 (= H138), N160 (≠ G139), D161 (= D140), H197 (= H176)
3uowA Crystal structure of pf10_0123, a gmp synthetase from plasmodium falciparum
38% identity, 99% coverage: 8:520/520 of query aligns to 2:517/517 of 3uowA
- active site: G53 (≠ S59), C84 (= C86), Y85 (= Y87), H198 (= H176), E200 (= E178), D255 (= D234), K381 (= K376)
- binding xanthosine-5'-monophosphate: R325 (= R303), P404 (= P399), G405 (= G400), P406 (= P401), Q446 (= Q441), K509 (= K512), T513 (= T516), I514 (= I517), E515 (= E518)
3uowB Crystal structure of pf10_0123, a gmp synthetase from plasmodium falciparum
39% identity, 98% coverage: 10:520/520 of query aligns to 2:477/477 of 3uowB
- active site: G47 (≠ S59), C67 (= C86), Y68 (= Y87), H162 (= H176), E164 (= E178), D218 (= D234), K340 (= K376)
- binding xanthosine-5'-monophosphate: R288 (= R303), P363 (= P399), G364 (= G400), P365 (= P401), Q405 (= Q441), K469 (= K512), T473 (= T516), I474 (= I517), E475 (= E518)
6jp9A Crsytal structure of a xmp complexed atppase subunit of m. Jannaschii gmp synthetase (see paper)
51% identity, 60% coverage: 208:520/520 of query aligns to 7:298/298 of 6jp9A
2vxoB Human gmp synthetase in complex with xmp (see paper)
36% identity, 96% coverage: 9:507/520 of query aligns to 5:527/658 of 2vxoB